Australia markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
54.95-0.08 (-0.15%)
At close: 04:00PM EST
54.48 -0.47 (-0.86%)
After hours: 07:50PM EST
Full screen
Trade prices are not sourced from all markets
Previous close55.03
Bid54.99 x 1100
Ask54.93 x 800
Day's range54.52 - 55.05
52-week range44.35 - 56.22
Avg. volume7,936,195
Market cap80.501B
Beta (5Y monthly)0.78
PE ratio (TTM)67.01
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.

    Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain. The Intracept system, a basivertebral nerve ablation therapy, will be an addition to the Boston Scientific chronic pain portfolio that includes spinal cord stimulation, radiofrequency

  • PR Newswire

    Boston Scientific to Participate in Stifel's 2023 Healthcare Conference

    Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2023 Healthcare Conference on Tuesday, November 14, 2023.

  • PR Newswire


    Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.527 billion during the third quarter of 2023, growing 11.2 percent on a reported basis, 11.1 percent on an operational1 basis and 10.2 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $505 million or $0.34 per share (EPS), compared to $174 million or $0.12 per share a year ago, and achieved adjusted3 EPS of $0.50 for